Compositions comprising coformulation of anti-PD-L1 and Anti-CTLA-4 antibodies

• 收藏
• 分享

专利权人:

LLC;MedImmune

发明人:

Du, Jiali,Shah, Ambarish

申请号：

AU2017257505

公开号：

AU2017257505A1

申请日:

2017.04.24

申请国别(地区):

AU

年份:

2018

代理人:

摘要：

Provided herein are compositions comprising coformulation of anti-PD-Ll and anti-CTLA-4 antibodies, or antigen-binding fragments thereof, and methods of making and using such compositions. In various aspects, stable coformulations of the anti-PD-Ll antibody durvalumab (MEDI4736) and the anti-CTLA-4 antibody tremelimumab are provided.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/